Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses (Details)

v3.22.1
Accrued Expenses (Details) - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Accrued Expenses    
Accrued compensation $ 236,851 $ 532,678
Accrued interest on preferred members' interests 188,085 188,085
Accrued clinical research costs 1,021,220 138,522
Accrued director fees 46,500 31,000
Accrued professional fees 41,350 24,100
Other miscellaneous accrued expenses 12,500 7,375
Accrued expenses $ 1,546,506 $ 921,760